Share：
Share this content in WeChat
X
[Chinese][PDF]117570
• Clinical Article •
The correlation between brain MR amide proton imaging and scores of clinical psychometric scales in patients with Alzheimer's disease
WANG Rui  BAN Yun-qing  LI Chun-mei  LOU Bao-hui  ZHANG Chen  CHEN Min 

DOI:10.12015/issn.1674-8034.2018.03.001.


[Abstract] Objective: To evaluate the correlation between MR amide proton transfer (APT) imaging values of cerebral structures and neuropsychological scores in patients with Alzheimer's disease (AD).Materials and Methods: Twenty-one AD patients and 19 age- and sex- matched normal controls underwent APT and structural MR imaging. The magnetic resonance ratio asymmetry (MTRasym) values at 3.5 ppm of bilateral hippocampi (Hc), temporal white matter regions, occipital white matter regions and cerebral peduncles were measured on the oblique axial APT images. All the subjects were evaluated by Mini-Mental State Examination (MMSE) and clinical dementia rating (CDR). MTRasym (3.5 ppm) values of the cerebral structures between two groups were compared with independent-samples t test. Controlling for age and years of education, partial correlation analysis was used to investigate the correlation between the various MR imaging measures and MMSE, CDR scores among all the subjects.Results: Compared to normal controls, MTRasym (3.5 ppm) in bilateral hippocampi were significantly increased in AD patients [right: (0.86±0.32)% and (1.42±0.35)%, t=5.158, P=0.000; left: (0.84±0.31)% and (1.39±0.33)%. t=5.225, P=0.000]. MTRasym (3.5 ppm) values of bilateral Hc were significantly negatively correlated with MMSE scores (right r=-0.637, P=0.000. left r=-0.611, P=0.000) and positively correlated with CDR scores (right r=0.686, P=0.000. left r=0.658, P=0.000).Conclusions: APT imaging can show sensitively hippocampal abnormal metabolite based on increased proteins and peptides in patients with AD, which suggests the technique is a useful tool to diagnose AD and monitor the disease.
[Keywords] Alzheimer's disease；Hippocampus；Magnetic resonance imaging

WANG Rui Department of Radiology, Beijing Hospital, Beijing 100730, China

BAN Yun-qing Xinjiang Medical University Fifth Hospitall, Wulumuqi 830011, China

LI Chun-mei Department of Radiology, Beijing Hospital, Beijing 100730, China

LOU Bao-hui Department of Radiology, Beijing Hospital, Beijing 100730, China

ZHANG Chen Department of Radiology, Beijing Hospital, Beijing 100730, China

CHEN Min* Department of Radiology, Beijing Hospital, Beijing 100730, China

*Correspondence to: Chen M, E-mail: cjr.chenmin@vip.163.com

Conflicts of interest   None.

ACKNOWLEDGMENTS  This research is funded by the National Natural Science Foundation of China No. 81771826, 81361120392 and 81401404 Beijing Natural Science Foundation No. 7162171 Beijing Hospital level No. bj-2015-142
Received  2017-09-29
Accepted  2018-01-30
DOI: 10.12015/issn.1674-8034.2018.03.001
DOI:10.12015/issn.1674-8034.2018.03.001.

[1]
Viola KL, Sbarboro J, Sureka R, et al. Towards non-invasive diagnostic imaging of early-stage Alzheimer's disease. Nat Nanotechnol, 2015, 10(1): 91-98.
[2]
Kaneta T, Katsuse O, Hirano T, et al. Head-to-head visual comparison between brain perfusion spect and arterial spin-labeling MRI with different postlabeling delays in Alzheimer disease. AJNR Am J Neuroradiol, 2017, 38(8): 1562-1568.
[3]
Peden AH, Ironside JW. Molecular pathology in neurodegenerative diseases. Current Drug Targets, 2012, 13(12): 1548-1559.
[4]
Zhou J, Tryggestad E, Wen Z, et al. Differentiation between glioma and radiation necrosis using molecular magnetic resonance imaging of endogenous proteins and peptides. Nature Med, 2011, 17(1): 130-134.
[5]
Jäger M, Bottlender R, Strauss A, et al. Fifteen-year follow-up of diagnostic and statistical manual of mental disorders, fourth edition depressive disorders: the prognostic significance of psychotic features. Compr Psychiatry, 2005, 46(5): 322-327.
[6]
McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and human services task force on Alzheimer's disease. Neurology, 1984, 34(7): 939-944.
[7]
Guo Y, Zhou IY, Chan ST, et al. pH-sensitive MRI demarcates graded tissue acidification during acute stroke-pH specificity enhancement with magnetization transfer and relaxation-normalized amide proton transfer (APT) MRI. Neuroimage, 2016, 141: 242-249.
[8]
Jokivarsi KT, Gröhn HI, Gröhn OH, et al. Proton transfer ratio, lactate, and intracellular pH in acute cerebral ischemia. Magn Reson Med, 2007, 57(4): 647-653.
[9]
Zhao X, Wen Z, Huang F, et al. Saturation power dependence of amide proton transfer image contrasts in human brain tumors and strokes at 3 T. Magn Reson Med, 2011, 66(4): 1033-1041.
[10]
Yuan J, Chen S, King AD, et al. Amide proton transfer-weighted imaging of the head and neck at 3 T: a feasibility study on healthy human subjects and patients with head and neck cancer. NMR Biomed, 2014, 27(10): 1239-1247.
[11]
Zhou J, Zhu H, Lim M, et al. Three-dimensional amide proton transfer MR imaging of gliomas: initial experience and comparison with gadolinium enhancement. J Magn Reson Imaging, 2013, 38(5): 1119-1128.
[12]
Li C, Peng S, Wang R, et al. Chemical exchange saturation transfer MR imaging of MR imaging of Parkinson's disease at 3 Tesla. Eur Radiol, 2014, 24(10): 2631-2639.
[13]
Larson Me, Lesné Se. Soluble Aβ oligomer production and toxicity. J Neurochem, 2012, 120(Suppl 1): 125-139.
[14]
Köpke E, Tung YC, Shaikh S, et al. Microtubule-associated protein tau: Abnormal phosphorylation of non-paired helical filament pool in Alzheimer disease. J Biol Chem, 1993, 268(32): 24374-24384.
[15]
Xu G, Stevens SM Jr, Moore BD, et al. Cytosolic proteins lose solubility as amyloid deposits in a transgenic mouse model of Alzheimer-typeamyloidosis. Hum Mol Genet, 2013, 22(14): 2765-2774.
[16]
Amador-Ortiz C, Lin WL, Ahmed Z, et al. TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease. Ann Neurol, 2007, 61(5): 435-445.
[17]
Sudre CH, Cardoso MJ, Frost C, et, al. APOE ε4 status is associated with white matter hyperintensities volume accumulation rate independent of AD diagnosis. Neurobiol Aging, 2017, 53: 67-75.
[18]
Liu Y, Yu JT, Wang HF, et al. Association between NME8 locus polymorphism and cognitive decline, cerebrospinal fluid and neuroimaging biomarkers in Alzheimer's disease. PLoS One, 2014, 9(12): e114777.

PREV MRI quantitative research progress of sacroiliac joint changes in patients with ankylosing spondylitis
NEXT Preliminary research of the classification of the brain acute stroke by diffusion kurtosis imaging parameters
  


LINK


Tel & Fax: +8610-67113815    E-mail: editor@cjmri.cn